Specific recognition of DNA by small molecules

Current Medicinal Chemistry

Volumn 17, Issue 2, 2010, Pages 173-189

  Du, Y H ^a   Huang, J ^a   Weng, X C ^a   Zhou, X ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

DNA specific recognition; Interaction; Small molecules

Indexed keywords

2,5 BIS(4 AMIDINOPHENYL)FURAN; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; ADENINE; AMILORIDE; CHELERYTHRINE; CISPLATIN DERIVATIVE; CONGOCIDINE; CYTOSINE; DACTINOMYCIN; DIMINAZENE ACETURATE; DISTAMYCIN A; DNA; DNA Z; FLAVINE MONONUCLEOTIDE; GUANINE; GUANINE QUADRUPLEX; LEXITROPSIN; LUMAZINE; MACROCYCLIC COMPOUND; NAPHTHYRIDINE DERIVATIVE; PENTAMIDINE; PORPHYRIN DERIVATIVE; PTERIN; RACHELMYCIN; RHODIUM COMPLEX; RIBOFLAVIN; SANGUINARINE; THYMINE;

BINDING AFFINITY; BINDING SITE; CHEMICAL STRUCTURE; DNA BINDING; DNA RNA HYBRIDIZATION; DNA STRUCTURE; DRUG BINDING SITE; DRUG DESIGN; DRUG DNA INTERACTION; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; HUMAN; HYDROGEN BOND; MISMATCH REPAIR; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN SECONDARY STRUCTURE; REVIEW; TRINUCLEOTIDE REPEAT;

DNA; DRUG DISCOVERY; HUMANS; MOLECULAR WEIGHT; PHARMACEUTICAL PREPARATIONS; SUBSTRATE SPECIFICITY;

EID: 77149164168     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710790112648     Document Type: Review

References (178)

1. Watson, J.D., Crick, F.H. Genetical implications of the structure of deoxyribonucleic acid. Nature, 1953, 171, 964-967.
2. Snyder, R.D.; Gilles, P.J. Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells. Environ. Mol. Mutagen, 2002, 40, 266-276.
3. Snyder, R.D.; Amone, M.R. Putative identification of functional interactions between DNA intercalating agents and topoisomerase II using the V79 in vitro micronucleus assay. Mutat. Res., 2002, 503, 21-35.
4. Simon, R.; Wang, S-J. Use of genomic signatures in therapeutics development. Pharmacogenom. J., 2006, 6, 166-173.
5. Bischoff, G.; Hoffmann, S. DNA-binding of drugs used in medicinal therapies. Curr. Med. Chem., 2002, 9, 312-348.
6. Han, X.; Gao, X. Sequence specific recognition of ligand-DNA complexes studied by NMR. Curr. Med. Chem., 2001, 8, 551-581.
7. Palchaudhuri, R.; Hergenrother, P. J. DNA as a Target for Anti-Cancer Compounds: Methods to Determine the Mode of Binding and the Mechanism of Action. Curr. Opin. Biotechnol., 2007, 18, 497-503.
8. Neidle, S.; Nunn, C. M. Crystal structures of nucleic acids and their drug complexes. Nat. Prod. Rep., 1998, 15, 1-15.
9. Bischoff, G., Hoffmann, S. DNA-binding of drugs used in medicinal therapies. Curr. Med. Chem., 2002, 9, 312-48.
10. Waring, M. J. Sequence-specific DNA Binding Agents, Royal Society of Chemistry, 2006.
11. Neidle, S., Pearl, L. H., Skelly, J. V. DNA structure and perturbation by drug binding. Biochem. J., 1987, 243, 1-13.
12. Lindahl, T.; Nyberg, B. Rate of depurination of native deoxyribonucleic acid. Biochemistry, 1972, 11, 3610-3618.
13. Lindahl, T. Instability and decay of the primary structure of DNA. Nature, 1993, 362, 709-715.
14. Demole, B.; Harrison, L. Repair of oxidative damage to DNA:enzymology and biology. Annu. Rev. Biochem., 1994, 63, 915-948.
15. Sankaran, N. B.; Nishizawa, S.; Seino, T.; Yoshimoto, K.; Teramae, N. Abasic sites-containing oligodeoxynucleotides as aptamers for riboflavin. Angew. Chem. Int. Ed., 2006, 45, 1563-1568.
16. Yoshimoto, K.; Nishizawa, S., Teramae, N. Use of abasic site containing DNA strands for nucleobase recognition in water. J. Am. Chem. Soc., 2003, 125, 8982-8983.
17. Sato, Y.; Seino, T.; Nishizawa, S., Teramae, N. Strong binding of naphthyridine derivatives to cytosine in an AP site-containing DNA duplex and their application to fluorescence detection of single nucleotide polymorphisms. Nucleic Acids Symp. Ser., 2007, 51, 313-314.
18. Ichihashi, T., Sato, Y., Seino, T., Nishizawa, S., Teramae, N. Effect of an alkyl amino group on the binding of 1,8-naphthyridines to AP site-containing DNA duplexes. Nucleic Acids Symp. Ser., 2008, 52, 117-118.
19. Kageyama, T., Sato, Y., Nishizawa, S., Teramae, N. Competitive binding of small ligands to nucleobases in AP site-containing DNA duplexes. Nucleic Acids Symp. Ser., 2008, 52, 119-20.
20. Kanai, E., Nishizawa, S., Teramae, N. A pteridine derivative with electron-withdrawing groups for binding and sensing of nucleobases in AP site-containing DNA duplexes. Nucleic Acids Symp. Ser., 2008, 52, 115-6.
21. Yoshimoto, K.; Xu, C. Y.; Nishizawa, S.; Haga, T.; Satake, H.; Teramae, N. Fluorescence detection of guanine-adenine transition by a hydrogen bond forming small compound. Chem. Comm., 2003, 24, 2960-2961
22. Dai, Q.; Xu, C.-Y.; Yoshimoto, K.; Nishizawa, S.; Taramae, N. Enhancement of Binding Ability of a Ligand for Nucleobase Recognition by Introducing a Methyl Group. Anal. Sci., 2006, 22, 201-203.
23. Rajendar, B., Rajendran, A., Sato, Y., Nishizawa, S., Teramae, N. Effect of Methyl Substitution in a Ligand on the Selectivity and Binding Affinity for a Nucleobase: A Case Study with Isoxanthopterin and Its Derivatives. Bioorg. Med. Chem., 2009, 17, 351-9.
24. Ragendar, B.; Nishizawa, S.; Teramae, N. Alloxazine as a ligand for selective binding to adenine opposite AP sites in DNA duplexes and analysis of single-nucleotide polymorhisms. Org. Biomol. Chem., 2008, 6, 670-673.
25. Zhiqiang, Y.; Rajendar, B.; Dai, Q.; Nishizawa, S.; Teramae, N. 6,7-Dimethyl lumazine as a potential ligand for selective recognition of adenine opposite abasic sites in DNA duplexes. Chem. Comm., 2008, 6588-6590.
26. Zhao, C-X.; Dai, Q.; Seino, T.; Cui, Y-Y.; Nishizawa, S.; Teramae, N. Strong and Selective Binding of Amiloride to Thymine Base Opposite AP Sites in DNA Duplexes: Simultaneous Binding to DNA Phosphate Backbone. Chem. Commun., 2006, 1185-1187.
27. Rajendran, A., Thiagarajan, V., Rajendar, B., Nishizawa, S., Teramae, N. Simultaneous recognition of nucleobase and sites of DNA damage: Effect of tethered cation on the binding affinity. Biochim. Biophys. Acta, 2009, 1790, 95-100.
28. Miura, S.; Ono, K.; Watanabe, M.; Nishizawa, S.; Teramae, N. A surface plasmon resonance sensor based on 3,5-diaminopyrazine with a high selectivity for thymine in AP site-containing DNA duplex. Nucleic Acids Symp. Ser., 2008, 52, 123-124.
29. Zhao, C.; Rajendran, A.; Dai, Q.; Nishizawa, S.; Teramae, N. A Pyrazine-based Fluorescence-enhancing ligand with a high selectivity for thymine in AP site-containing DNA duplexes. Anal. Sci., 2008, 24, 693-695.
30. Iyer, R.; Pluciennik, A.; Burdett, V.; Modrich, P. DNA mismatch repair:functions and mechanisms. Chem. Rev., 2006, 106, 302-323.
31. Nakatani, K.; Sando, S.; Saito, I. Recognition of a single guanine Bulge by 2-Acylamino-1,8-naphthyridine. J. Am. Chem. Soc., 2000, 122, 2172-2177.
32. Nakatani, K.; Sando, S.; Yoshida, K.; Saito, I. Specific binding of 2-amino-1,8-naphthyridine into a single guanine bulge as evidenced by photooxidation of GG doublet. Bioorg. Med. Chem. Lett., 2001, 11, 335-337.
33. Nakatani, K.; Sando, S.; Yoshida, K.; Saito, I. Scanning of guanine-guanine mismatches in DNA by synthetic ligands using surface plasmon resonance assay. Nat. Biotechnol., 2001,19, 51-55.
34. Nakatani, K.; Sando, S.; Kumasawa, H.; Kikuchi, J.; Saito, I. Recognition of Guanine-Guanine Mismatch by Dimeric Form of 2-Amino-1,8-naphthyridine. J. Am. Chem. Soc., 2001, 123, 12650-12657.
35. Nakatani, K.; Sando, S.; Saito, I. Improved selectivity for the binding of naphthyridine dimer to guanine-guanine mismatch. Bioorg. Med. Chem., 2001, 9, 2381-2385.
36. Hagihara, S.; Kumasawa, H.; Goto, Y.; Hayashi, G.; Kobori, A.; Saito, I.; Nakatani, K. Nucleic Acids Res., 2004, 32, 276-286.
37. Kobori, A.; Horie, S.; Suda, H.; Saito, I.; Nakatani, K. The SPR sensor detecting the cytosine-cytosine mismatches. J. Am. Chem. Soc., 2004, 126, 557-562.
38. Zeglis, B. M.; Barton, J. K. DNA base mismatch detection with bulky rhodium intercalators: Synthesis and applications. Nat. Protocols, 2007, 2, 357-371.
39. Zegli, B. M., Barton, J. K. Binding of Ru(bpy)2(eilatin)2+ to Matched and Mismatched DNA. Inorg. Chem., 2008, 47, 6452-7.
40. Ernst, R. J., Song, H., Barton, J. K. DNA Mismatch binding and antiproliferative activity of rhodium metalloinsertors. J. Am. Chem. Soc., 2009, 131, 2359-66.
41. Jackson, B. A.; Barton, J. K. Recognition of DNA base mismatches by a rhodium intercalator. J. Am. Chem. Soc., 1997, 119, 12986-12987.
42. Jackson, B. A.; Alekseyev, V. Y.; Barton, J. K. A Versatile mismatch recognition agent: Specific cleavage of a plasmid DNA at a single base mispair. Biochemistry, 1999, 38, 4655-4662.
43. Jackson, B. A.; Barton, J. K. Recognition of base mismatches in DNA by 5,6-chrysenequinone diimine complexes of rhodium(III): A proposed mechanism for preferential binding in destabilized regions of the double helix. Biochemistry, 2000, 39, 6176-6182.
44. Pierre, V. P.; Kaiser, J. T.; Barton, J. K. Insights into finding a mismatch through the structure of a mispaired DNA bound by a rhodium intercalator. Proc. Natl. Acad. Sci. U.S.A., 2007, 104, 429-434.
45. Cordier, C.; Pierre, V. P.; Barton, J. K. Insertion of a bulky rhodium complex into a DNA cytosine-cytosine mismatch: An NMR solution study. J. Am. Chem. Soc., 2007, 129, 12287-12296.
46. Junicke, H.; Hart, J. R.; Kisko, J.; Glebov, O.; Kirsch, I. R.; Barton, J. K. A rhodium(III) complex for high affinity DNA base pair mismatch recognition. Proc. Natl. Acad. Sci. U.S.A., 2003, 100, 3737-3742.
47. Zeglis, B. M.; Barton, J. K. DNA base mismatch detection with bulky rhodium intercalators: Synthesis and applications. Nat. Protoc., 2007, 2, 357-371
48. Slupphaug, G.; Mol, C. D.; Kavli, B.; Arvai, A.; Krokan, H. E.; Tainer, J. A. A nucleotide-flipping mechanism from the structure of human uracil-DNA glycosylase bound to DNA. Nature, 1996, 384, 87-92.
49. Parihk, S.S. Mol, C. D.; Slupphaug, G.; Bharati, S.; Krokan, H. E.; Tainer, J. A. Base excision repair initiation revealed by crystal structures and binding kinetics of human uracil-DNA glycosylase with DNA. EMBO J. 1998, 17, 5214-5226.
50. David, A.; Bleimling, N.; Beuck, C.; Lehn, J. M.; Weinhold, E.; Teulade-Fichou, M. P. DNA Mismatch-Specific Base Flipping by a Bisacridine Macrocycle. ChemBioChem, 2003, 4, 1326-1331.
51. Bahr, M.; Gabelica, V.; Granzhan, A.; Weinhold, E.; Teulade-Fichou, M. P. Selective recognition of pyrimidine-pyrimidine DNA mismatches by distance-constrained macrocyclic bis-intercalators. Nucleic Acids Res., 2008, 36, 5000-5012.
52. Granzhan, A.; Teulade-Fichou, M. P. A Fluorescent Bisanthracene Macrocycle Discriminates between Matched and Mismatch-Containing DNA. Chem. Eur. J., 2008, 15, 1314-1318.
53. Priyakumar, U. D.; MacKerell, A. D. Computational approaches for investigating base flipping in oligonucleotides. Chem. Rev., 2006, 106, 489-505.
54. Dion, V.; Wilson, J.H. Instability and chromatin structure of expanded trinucleotide repeats. Trends Genet., 2009, 25, 288-297.
55. Nakatani, K.; Hagihara, S.; Goto, Y.; Kobori, A.; Hagihara, M.; Hayashi, G.; Kyo, M.; Nomura, M.; Mishima, M.; Kojima, C. Small-molecule ligand induces nucleotide flipping in (CAG)n trinucleotide repeats. Nat. Chem. Biol., 2005, 1, 39-43.
56. Amrane, S.; De Cian, A.; Rosu, F.; Kaiser, M.; De Pauw, E.; Teulade-Fichou, M-P.; Mergny, J-L. Identification of Trinucleotide Repeat Ligands with a FRET Melting Assay. ChemBioChem, 2008, 9, 1229 - 1234.
57. He, H.P.; Hagihara, M.; Nakatani, K. A Small Molecule Affecting the Replication of Trinucleotide Repeat d(GAA)n. Chem. Eur. J., 2009, 15, 10641 - 10648.
58. Turner, D. H. Bulges in nucleic acids. Curr. Opin. Struct. Biol., 1992, 2, 334-337.
59. Lilley, D. M. Kinking of DNA and RNA by base bulges. Proc. Natl. Acad. Sci. U.S.A., 1995, 92, 7140-7142.
60. Greenblatt, J.; Nodwell, J.R.; Mason, S.W. Transcriptional antitermination. Nature, 1993, 364, 401-406.
61. Xi, Z.; Goldber, I. H. Advances in DNA Sequence-specific Agents; Elsevier press: Netherlands, 2002; Vol. 4, pp. 75-103.
62. Ripley, L. S. Model for the participation of quasi-palindromic DNA sequences in frameshift mutation. Proc. Natl. Acad. Sic. USA, 1982, 79, 4128-4132.
63. Zhu, J.; Wartell, R. M. The effect of base sequence on the stability of RNA and DNA single base bulges. Biochemistry, 1999, 38, 15986-93.
64. Nakatani, K.; Sando, S.; Saito, I. Recognition of a Single Guanine Bulge by 2-Acylamino-1,8-naphthyridine. J. Am. Chem. Soc., 2000, 122, 2172-2177.
65. Xi, Z.; Zhang, R. Y.; Yu, Z. H.; Ouyang, D.; Huang, R. Q. Selective interaction between tylophorine B and bulged DNA. Bioorg. Med. Chem. Lett., 2005, 15, 2673-2677.
66. Bai, L. P.; Zhao, Z. Z.; Cai, Z. W.; Jiang, Z. H. Site-specific binding of chelerythrine to single cytosine and thymine bulges in DNA hairpins. Nucleic Acids Symp. Ser., 2006, 50, 197-198.
67. Bai, L. P.; Cai, Z. W.; Zhao, Z. Z.; Nakatani, K.; Jiang, Z. H. Chelerythrine and Sanguinarine to Single Pyrimidine. Bulges in Hairpin DNA. Anal. Bioanal. Chem., 2008, 392, 709-716.
68. Lauria, A.; Montalbano, A.; Barraja, P.; Dattolo, G.; Almerico, A. M. DNA minor groove binders: an overview on molecular modeling and QSAR approaches. Curr. Med.Chem., 2007, 14, 2136-2160.
69. Bailly C.; Chaires J. B. Sequence-specific DNA minor groove binders. Design and synthesis of netropsin and distamycin analogues. Bioconjug. Chem., 1998, 9, 513-538.
70. Fairley, T. A.; Tidwell, R. R.; Donkor, I.; Naiman, N. A.; Ohemeng, K. A.; Lombardy, R. J.; Bentley, J. A.; Cory, M. Alkyl-Linked and Aryl-Linked Bis(amidinobenzimidazoles) and Bis(amidinoindoles). J. Med. Chem., 1993, 36, 1746-1753.
71. Wierenga, W. Sequence-selective DNA-interactive antitumor agents. Drugs Future, 1991, 16, 741-750.
72. Queener, S. F. New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii. J. Med. Chem., 1995, 38, 4739-4759.
73. Nunn, C. M.; Neidle, S. Sequence-dependent drug binding to the minor groove of DNA: crystal structure of the DNA dodecamer d(CGCAAATTTGCG) 2 complexed with propamidine. J. Med. Chem., 1995, 38, 2317-2325.
74. Nguyen, B.; Lee, M. P.; Hamelberg, D.; Bailly, C.; Brun, R.; Neidle, S.; Wilson, W. D. Strong binding in the DNA minor groove by an aromatic diamidine with a shape that does not match the curvature of the groove. J. Am. Chem. Soc., 2002, 124, 13680-13681.
75. Nguyen, B.; Hamelberg, D.; Bailly, C.; Colson, P.; Stanek, J.; Brun, R.; Neidle, S.; Wilson, W. D. Characterization of a novel DNA minor-groove complex. Biophys. J., 2004, 86, 1028-1041.
76. Miao, Y.; Lee, M. P.; Parkinson, G. N.; Batista-Parra, A.; Ismail, M. A.; Neidle, S.; Boykin, D. W.; Wilson, W. D. Out of shape DNA minor groove binders: Induced fit interactions of heterocyclic dications with the DNA minor groove. Biochemistry, 2005, 44, 14701-14708.
77. Goodwin, K. D.; Lewis, M.A.; Tanious, F. A.; Tidwell, R.R.; Wilson, W. D.; Georgiadis, M. M.; Long, E. C. A high-throughput, high-resolution strategy for the study of site selective DNA binding agents: Analysis of a "highly-twisted" benzamidazole diamidine. J. Am. Chem. Soc., 2006, 128, 7846-7854.
78. White, S.; Szewczyk, J. W.; Turner, J. M.; Baird, E. E.; Dervan, P. B. Recognition of the four Watson-Crick base pairs in the DNA minor groove by synthetic ligands. Nature, 1998, 391, 468-471.
79. Dervan, P.B.; Doss, R.M.; Marques, M.A. Programmable DNA binding oligomers for control of transcription. Curr. Med. Chem. Anticancer Agents, 2005, 5, 373-387.
80. Mrksich, M.; Parks, M. E.; Dervan, P. B. Hairpin peptide motif. A new class of oligopeptides for sequence-specific recognition in the minor groove of double-helical DNA. J. Am. Chem. Soc., 1994, 116, 7983-7988.
81. Hang, W.; Minoshima, M.; Ugiyama, H. Base pair recognition of the stereochemically alpha-substituted gamma-turn of pyrroleimidazole hairpin polyamides. J. Am. Chem. Soc., 2006, 128, 14905-14912.
82. Hsu, C. F.; Phillips, J. W.; Trauger, J. W.; Farkas, M. E.; Belitsky, J. M.; Heckel, ; A.; Olenyuk, B. Z.; Puckett, J. W.; Wang, C. C. C.; Dervan, P. B. Completion of a programmable DNA-binding small molecule library. Tetrahedron, 2007, 63, 6146-6151.
83. Dose, C.; Farkas, M. E.; Chenoweth, D. M.; Dervan, P. B. Next generation hairpin polyamides with (R)-3,4-diaminobutyric acid turn unit. J. Am. Chem. Soc., 2008, 130, 6859-6866.
84. (a) Erkkila, K. E.; Odom, D. T.; Barton, J. K. Recognition and reaction of metallointercalators with DNA. Chem. Rev., 1999, 99, 2777-2796;
85. (b) Hurley, L. H. Secondary DNA structures as molecular targets for cancer therapeutics. Biochem. Soc. Trans., 2001, 29, 692-696;
86. (c) Sarai, A.; Kono, H. Protein-DNA recognition patterns and predictions. Annu. Rev. Biophys. Biomol. Struct., 2005, 34, 379-398.
87. Lu, J.; Sloan, S. R. Characterization, expression and evolution of mouse beta 2-glycoprotein I (apolipoprotein H). Biochem. Biophys. Res. Commun., 2002, 290, 1521-1528
88. Waring, M. J. DNA Modification and Cancer. Ann. Rev. Biochem. 1981, 50, 159-162.
89. Wadkins, R. M. Targeting DNA secondary structures. Curr. Med. Chem., 2007, 7, 1-15
90. Muller, J. G.; Paikoff S. J.; Rokita S. E.; Burrows C. J. DNA Modification Promoted by Water-Soluble Nickel(II) Salen Complexes: A Switch to DNA Alkylation. J. Inorg. Biochem., 1994, 54, 199-206.
91. Muller, J. G.; Chen, X. Y.; Dadiz, A. C.; Rokita S. E.; Burrows C. J. Ligand effects associated with the intrinsic selectivity of DNA oxidation promoted by nickel(II) macrocyclic complexes. J. Am. Chem. Soc., 1992, 114, 6407 - 6411.
92. Weng, X. C.; Huang, J.; Wu, S.; Ren, L. G.; Weng, L. W.; Zhu, S. G.; Zhou, X. Specific Recognition of Loop DNA by Dicationic Porphyrins. Chem. Biodever., 2007, 4, 1501-1507.
93. Bock, L. C.; Griffin, L. C.; Latham, J. A.; Vermaas, E. H.; Toole, J. J. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature, 1992, 355, 564-566
94. Lin, C. H.; Patel, D. J. Encapsulating an amino acid in a DNA fold. Nat. Struct. Biol., 1996, 3, 1046-1050.
95. Wang, Y. Y.; Liu, B. ATP detection using a label-free DNA aptamer and a cationic tetrahedralfluorene. Analyst, 2008, 133, 1593-1598.
96. Nutiu, R.; Li, Y. F. Structure-switching signaling aptamers. J. Am. Chem. Soc., 2003, 125, 4771-4778.
97. Yigit, M. V.; Mazumdar, D.; Kim, H-K.; Lee, J. H.; Odintsov, B.; Lu. Y. Smart "Turn-on" magnetic resonance contrast agents based on aptamer-functionalized superparamagnetic iron oxide nanoparticles. ChemBioChem, 2007, 8, 1675 -1678
98. Liu, J. W.; Lu, Yi. Non-Base Pairing DNA Provides a New Dimension for Controlling Aptamer-Linked Nanoparticles and Sensors. J. Am. Chem. Soc. 2007, 129, 8634 -8643.
99. (a) Laughlan,G.; Murchie, A. I.; Norman, D. G.; Moore, M. H.; Moody, P. C.; Lilley, D. M.; Luisi, B. The high-resolution crystal structure of a parallel-stranded guanine tetraplex. Science, 1994, 265, 520-524.
100. (b) Parkinson, G. N.; Lee, M. P. H.; Neidle, S. Crystal structure of parallel quadruplexes from human telomeric DNA. Nature 2002, 417, 876-880.
101. (a) Phan, A.T.; Kuryavyi, V.; Patel, D.J. DNA architecture: from G to Z. Curr. Opin. Struct. Biol., 2006, 16, 288-298;
102. (b) Patel, D.J.; Phan, A.T.; Kuryavyi, V. Human telomere, oncogenic promoter and 5'-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics. Nucleic Acids Res., 2007, 35, 7429-7455.
103. (a) Pagano, B.; Giancola, C. Energetics of quadruplex-drug recognition in anticancer therapy. Curr. Cancer Drug Targets, 2007, 7, 520-540;
104. (b) Neidle, S. ; Thurston, D. E. Chemical approaches to the discovery and development of cancer therapies. Nat. Rev. Cancer, 2005, 5, 285-296;
105. (c) Mergny, J. L.; Riou, J. F.; Mailliet, P.; Teulade-Fichou, M.-P. Gilson, E. Natural and pharmacological regulation of telomerase. Nucleic Acids Res., 2002, 30, 839-865;
106. (d) Neidle, S.; Parkinson, G. Telomere maintenance as a target for anticancer drug discovery. Nat. Rev. Drug Discov., 2002, 1, 383-393;
107. (e) Hurley, L. H. DNA and its associated processes as targets for cancer therapy. Nat. Rev. Cancer, 2002, 2, 188-200;
108. (f) Kell, L. Targeting the Limitless Replicative Potential of Cancer: The Telomerase/Telomere Pathway. Clin. Cancer Res., 2007, 13, 4960-4963;
109. (g) Maizels, N. Dynamic roles for G4 DNA in the biology of eukaryotic cells. Nat. Struct. Mol. Biol., 2006, 13, 1055-1059
110. Alberti, P.; Bourdoncle, A.; Sacca, B.; Lacroix, L.; Mergny, J. L. DNA nanomachines and nanostructures involving quadruplexes. Org. Biomol. Chem., 2006, 4, 3383-3391.
111. Blackburn, E.H. Telomeres: No end in sight. Cell, 1994, 77,621-623.
112. Sen, D.; Gilbert, W. Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its implications for meiosis. Nature, 1988, 334, 364-366.
113. Evans, T.; Schon, E.; Gora-Maslak, G.; Patterson, J.; Efstratiadis, A. Sl-hypersensitive sites in eukaryotic promoter regions. Nucleic Acids Res 1984, 12, 8043-8058.
114. Kilpatrick, M. W.; Torri, A.; Kang, D. S.; Engler, J. A.; Wells, R. D. Unusual DNA structures in the adenovirus genome. J. Biol. Chem., 1986, 261, 11350-11354.
115. Fry, M.; Loeb, L. A. The fragile X syndrome d(CGG)n nucleotide repeats form a stable tetrahelical structure. Proc. Natl. Acad. Sci. USA, 1994, 91, 4950-4954.
116. Patel, D. J.; Bouaziz, S.; Kettani, A.; Wang, Y. In Oxford Handbook of Nucleic Acid Structure (Ed Neidle, S.) Oxford University Press, 1999, pp 339-453.
117. (a) Ou, T. M.; Lu, Y. J.; Tan, J. H.; Huang, Z. S.; Wong, K. Y.; Gu, L. Q. G-quadruplexes: targets in anticancer drug design. ChemMedChem, 2008, 3, 690-713.
118. (b) Mergny, J. L.; Hélène, C. G-quadraplex DNA: a target for drug design. Nat. Med., 1998, 4, 1366-1367.
119. Juskowiak, B.; Takenaka, S. Fluorescence resonance energy transfer in the studies of guanine quadruplexes. Methods Mol. Biol. 2006, 335, 311-341.
120. Seenisamy , J.; Bashyam, S.; Gokhale, V.; Vankayalapati, H.; Sun, D.; Siddiqui-Jain, A.; Streiner, N.; Shin-ya, K.; White, E.; Wilson, W. D. ; Hurley, L. H. Design and synthesis of an expanded porphyrin that has selectivity for the c-MYC G-quadruplex structure. J. Am. Chem. Soc., 2005, 127, 2944-2959.
121. (a) Rossetti, L.; Franceschin, M.; Bianco, A.; Ortaggi, G.; Savino, M. Perylene diimides with different side chains are selective in inducing different G-quadruplex DNA structures and in inhibiting telomerase. Bioorg. Med. Chem. Lett., 2002, 12, 2527-2533;
122. (b) Wheelhouse, R. T.; Jennings, S. A.; Philips, V. A.; Pletsas, D.; Murphy, P. M.; Garbett, N. C.; Chaires, J. B.; Jenkins, T. C. Design, synthesis, and evaluation of novel biarylpyrimidines: A New class of ligand for unusual nucleic acid structures. J. Med. Chem., 2006, 49, 5187-5198.
123. Dixon, I. M.; Lopez, F.; Tejera, A. M.; Estève, J. P.; Blasco, M. A.; Pratviel, G.; Meunier, B. A G-quadruplex ligand with 10000-fold selectivity over duplex DNA. J. Am. Chem. Soc., 2007, 129, 1502-1503.
124. (a) Seenisamy, J.; Bashyam, S.; Gokhale, V.; Vankayalapati, H.; Sun, D.; Siddiqui-Jain, A.; Streiner, N.; Shin-ya, K.; White, E.; Wilson, W. D.; Hurley, L. H. Design and synthesis of an expanded porphyrin that has selectivity for the c-MYC G-quadruplex structure. J. Am. Chem. Soc., 2005, 127, 2944-2959;
125. (b) Rezler, E. M.; Seenisamy, J.; Bashyam, S.; Kim, M. Y.; White, E.; Wilson, W. D.; Hurley, L. H. Telomestatin and diseleno sapphyrin bind selectively to two different forms of the human telomeric G-quadruplex structure. J. Am. Chem. Soc., 2005, 127, 9439-9447.
126. Goncalves, D. P. N.; Rodriguez, R.; Balasubramanian, S.; Sanders, K. M. J. Tetramethylpyridiniumporphyrazines-a new class of Gquadruplex inducing and stabilising ligands. Chem. Commun., 2006, 4685-4687.
127. Fu, B. Q.; Huang, J.; Ren, L. G.; Weng, X. C.; Zhou, Y. Y.; Du, Y. H.; Wu, X. J.; Zhou, X.; Yang, G. F. Cationic corrole derivatives: a new family of G-quadruplex inducing and stabilizing ligands. Chem. Commun., 2007, 3264-3266.
128. Arora, A.; Maiti, S. Effect of Loop Orientation on Quadruplex-TMPyP4 Interaction. J. Phys. Chem. B, 2008, 112, 8151-8159.
129. Huber, M.D.; Lee, D.C.; Maizeles, N. G4 DNA unwinding by BLM and Sgs1p: substrate specificity and substrate-specific inhibition. Nucleic Acids Res. 2002, 30, 3954-3961.
130. Sun, D.; Thompson, B.; Cathers, B. E.; Salazar, M.; Kerwin, S. M.; Trent, J. O.; Jenkins, T. C.; Neidle, S.; Hurley, L. H. Inhibition of human telomerase by a G-quadruplex-interactive compound. J. Med. Chem. 1997, 40, 2113-2116.
131. Campbell, N. H.; Parkinson, G. N.; Reszka, A. P.; Neidle, S. Structural basis of DNA quadruplex recognition by an acridine drug. J. Am. Chem. Soc., 2008, 130, 6722-6724.
132. Mergny, J. L.; Lacroix, L.; Teulade-Fichou,M. P.; Hounsou,C.; Guittat,L.; Hoarau,M.; Arimondo, P. B.; Vigneron, J. P.; Lehn, J. M. Rioui, J. F.; Garestier,T.; Hélène, C. Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay. Proc. Natl. Acad. Sci. USA, 2001, 98, 3062-3067.
133. Teulade-Fichou,M. P.; Carrasco,C.; Guittat, L.; Bailly, C.; Alberti, P.; Mergny, J. L.; David, A.; Lehn, J. M.; Wilson, W. D. Selective Recognition of G-Quadruplex telomeric DNA by a Bis(quinacridine) macrocycle. J. Am. Chem. Soc., 2003, 125, 4732-4740.
134. Hounsou, C.; Guittat, L.; Monchaud, D.; Jourdan, M.; Saettel, N.; Mergny, J. L.; Teulade-Fichou, M. P. G-Quadruplex recognition by quinacridines: a SAR, NMR, and biological study. ChemMedChem, 2007, 2, 655-666.
135. De Cian, A.; Mergny, J. L. Quadruplex ligands may act as molecular chaperones for tetramolecular quadruplex formation. Nucleic Acids Res., 2007, 35, 2483-2493.
136. Monchaud, D.; Yang, P.; Lacroix, L.; Teulade-Fichou, M. P.; Mergny, J. L. A Metal-mediated conformational switch controls Gquadruplex binding affinity. Angew. Chem. Int. Ed., 2008, 47, 4858-4861.
137. De Cian, A.; DeLemos, E.; Mergny, J. L.; Teulade-Fichou, M. P.; Monchaud, D. Highly efficient G-quadruplex recognition by bisquinolinium compounds. J. Am. Chem. Soc., 2007, 129, 1856-1857.
138. Dash, J.; Shirude, P. S.; Balasubramanian, S. G-quadruplex recognition by bis-indole carboxamides. Chem. Commun., 2008, 3055-3057
139. Li, G.; Huang, J.; Zhang, M.; Zhou, Y.; Zhang, D.; Wu, Z.; Wang, S.; Weng, X.; Zhou, X.; Yang, G. Bis(benzimidazole)pyridine derivative as a new class of G-quadruplex inducing and stabilizing ligand. Chem. Commun., 2008, 4564-4566.
140. Sun, D.; Guo, K.; Rusche, J. J.; Hurley, L. H. Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents. Nucleic Acids Res., 2005, 33, 6070-6080.
141. Shin-ya, K.; Wierzba, K.; Matsuo, K. I.; Ohtani, T.; Yamada, Y.; Furihata, K.; Hayakawa, Y.; Seto, H. Telomestatin, a Novel Telomerase Inhibitor from Streptomyces anulatus. J. Am. Chem. Soc., 2001, 123, 1262-1263.
142. (a) Kim,M. Y.; Vankayalapati,H.; Shin-ya, K.; Wierzba, K.; Hurley, L. H. Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular Gquadruplex. J. Am.Chem. Soc., 2002, 124, 2098-2099;
143. (b) Rosu, F.; Gabelica, V.; Shin-ya, K.; De Paw, E. Telomestatin-induced stabilization of the human telomeric DNA quadruplex monitored by electrospray mass spectrometry. Chem. Commun., 2003, 2702-2703;
144. (c) Shin-ya, K. Novel antitumor and neuroprotective substances discovered by characteristic screenings based on specific molecular targets. Biosci., Biotechnol., Biochem., 2005, 69, 867-872;
145. (d) Binz, N., Shalaby, T.; Rivera, P.; Shin-ya, K.; Grotzer, M. A. Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells. Eur. J. Cancer, 2005, 41, 2873-2881;
146. (e) Tahara, H.; Shin-ya, K.; Seimiya, H.; Yamada, H.; Tsuruo, T.; Ide, T. G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3' telomeric overhang in cancer cells. Oncogene, 2006, 25, 1955-1966;
147. (f) Tauchi, T.; Shin-Ya, K.; Sashida, G.; Sumi, M.; Okabe, S.; Ohyashiki, J. H.; Ohyashiki, K. Telomerase inhibition with a novel G-quadruplex- interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia. Oncogene, 2006, 25, 5719-5725;
148. (g) Gomez, D.; O'Donohue, M. F.; Wenner, T.; Douarre, C.; Macadre, J.; Koebel, P.; Giraud-Panis, M. J.; Kaplan, H.; Kolkes, A.; Shin-ya, K.; Riou, J. F. The Gquadruplex ligand telomestatin inhibits POT1 Binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells. Cancer Res., 2006, 66, 6908-6912;
149. (h) Gomez, D.; Wenner, T.; Brassart, B.; Douarre, C.; O'Donohue, M. F.; El Khoury, V.; Shin-ya, K.; Morjani, H.; Trentesaux, C.; Riou, J. F. Telomestatin-induced telomere uncapping is modulated by POT1 through G-overhang extension in HT1080 human tumor cells. J. Biol. Chem. 2006, 281, 38721-38729.
150. Doi,T.; Yoshida, M.; Shin-ya, K.; Takahashi, T.; Total synthesis of (R)-telomestatin. Org. Lett., 2006, 8, 4165-4167.
151. Rzuczek, S. G.; Pilch, D. S.; LaVoie, E. J.; Rice, J. E. Lysinyl macrocyclic hexaoxazoles: Synthesis and selective G-quadruplex stabilizing properties. Bioorg. Med. Chem. Lett., 2008, 18, 913-917.
152. Tera, M.; Ishizuka, H.; Takagi, M.; Suganuma, M.; Shin-ya, K.; Nagasawa, K. Macrocyclic hexaoxazoles as sequence- and modeselective G-quadruplex binders. Angew. Chem. Int. Ed., 2008, 47, 5557-5560.
153. Jantos, K.; Rodriguez, R.; Ladame, S.; Shirude, P. S.; Balasubramanian, S. Oxazole-based peptide macrocycles: A new class of Gquadruplex binding ligands. J. Am. Chem. Soc., 2006, 128, 13662-13663.
154. Chakraborty, T. K.; Arora, A.; Roy, S.; Kumar, N.; Maiti, S. Furan based cyclic oligopeptides selectively target G-quadruplex. J. Med. Chem., 2007, 50, 5539-5542.
155. Kieltyka, R.; Fakhoury, J.; Moitessier, N.; Sleiman, H. F. Platinum phenanthroimidazole complexes as G-quadruplex DNA selective binders. Chem. Eur. J. 2008, 14, 1145 - 1154
156. Kieltyka, R.; Englebienne, P.; Fakhoury, J.; Autexier, C.; Moitessier, N.; Sleiman, H. F. A Platinum Supramolecular square as an effective G-quadruplex binder and telomerase inhibitor. J. Am. Chem. Soc. 2008, 130, 10040-10041
157. Bertrand, H.; Bombard, S.; Monchaud, D.; Teulade-Fichou, M. P. platinum-quinacridine hybrid as G-quadruplex-ligand. J. Biol. Inorg. Chem., 2007, 12, 1003-1014.
158. Ma, D. L.; Che, C. M.; Yan, S. C. Platinum(II) Complexes with dipyridophenazine ligands as human telomerase inhibitors and luminescent probes for G-quadruplex DNA. J. Am. Chem. Soc.2009, 131, 1835-1846.
159. Wang, A. H. J.; Quigley, G. J.; Kolpak, F. J.; Crawford, J. L.; van Boom, J. H.; Van der Marel, G.; Rich, A. Molecular structure of a left-handed double helical DNA fragment at atomic resolution. Nature, 1979, 282, 680-686.
160. Ha, S. C.; Lowenhaupt, K.; Rich, A.; Kim, Y. G.; Kim, K. K. Crystal structure of a junction between B-DNA and Z-DNA reveals two extruded bases. Nature, 2005, 437, 1183-1186.
161. (a) Wang, G.; Vasquez, K. M. Z-DNA, an active element in the genome. Front. Biosci. 2007, 1, 4424-4438.
162. (b) Herbert, A.; Rich, A. The Biology of Left-handed Z-DNA. J. Biol. Chem., 1996, 271, 11595-11598.
163. Barton, J. K. Metals and DNA: molecular left-handed complements. Science, 1986, 233, 727-734.
164. Chow, C. S.; Barton, J. K. Transition metal complexes as probes of nucleic acids. Methods Enzymol. 1992, 212, 219-242.
165. Barton, J. K.; Danishefsky, A. T.; Goldberg J. M. Tris(phenanthroline) ruthenium(II): stereoselectivity in binding to DNA. J. Am. Chem. Soc., 1984, 106, 2172-2176
166. Qu, X. G.; Trent, J. O.; Fokt, I.; Priebe, W.; Chaires, J. B. Allosteric, chiral-selective drug binding to DNA. Proc. Natl. Acad. Sci. USA, 2000, 97, 12032-12037.
167. Xu Yan.; Zhang, Y. X.; Sugiyama, H.; Umano, T.; Osuga, H.; Tanaka K. (P)-Helicene displays chiral selection in binding to ZDNA. J. Am. Chem. Soc., 2004, 126, 6566-6567.
168. Spingler, B.; Anions or cations: Who is in charge of inhibiting the nickel(II) promoted B- to Z-DNA transition? Inorg. Chem., 2005, 44, 831-833.
169. Shih ,H.-C.; Tang, N.; Burrows, C. J.; Rokita, S. E. Nickel-based probes of nucleic acid structure bind to guanine N7 but do not perturb a dynamic equilibrium of extrahelical guanine residues. J. Am. Chem. Soc., 1998, 120, 3284-3288.
170. Spingler B.; Antoni, P. M. To be dinuclear or not: Z-DNA induction by nickel complexes. Chem. Eur. J. 2007, 13, 6617 - 6622.
171. Thomas, T. J.; Thomas, T. Polyamine-induced Z-DNA conformation in plasmids containing (dA-dC)n.(dG-dT)n inserts and increased binding of lupus autoantibodies to the Z-DNA form of plasmids. Biochem. J. 1994, 298, 485-491.
172. Ohishi, H.; Odoko, M.; Grzeskowiak, K.; Hiyama, Y.; Tsukamoto, K.; Maezaki, N.; Ishida, T.; Tanaka, T.; Okabe, N.; Fukuyama, K.; Zhou, D-Y.; Nakatani, K. Polyamines stabilize left-handed ZDNA: using X-ray crystallographic analysis, we have found a new type of polyamine (PA) that stabilizes left-handed Z-DNA. Biochem. Biophys. Res. Commun., 2008, 366, 275-280.
173. Rodger, A.; Sanders, K. J.; Hannon, M. J.; Meistermann, I.; Parkinson, A.; Vidler, D. S.; Haworth, I. S. DNA structure control by polycationic species: Polyamine, cobalt ammines, and di-metallo transition metal chelates. Chirality, 2000, 12, 221-236.
174. Parkinson, A.; Hawken, M.; Hall, M.; Sanders, K. J.; Rodger, Amine induced Z-DNA in poly(dG-dC)̇poly(dG-dC): Circular dichroism and gel electrophoresis study. A. Phys. Chem. Chem. Phys., 2000, 2, 5469-5478.
175. Okamoto, A.; Ochia, Y.; Saito, I. Fluorometric sensing of the saltinduced B-Z DNA transition by combination of two pyrene-labeled nucleobases. Chem. Commun., 2005, 1128-1130.
176. Seo, Y. J.; Kim, B. H. Probing the B-to-Z-DNA duplex transition using terminally stacking ethynyl pyrene-modified adenosine and uridine bases. Chem. Commun., 2006, 150-152.
177. Balaz, M.; Napoli, M. D.; Holmes, A. E.; Mammana, A.; Nakanishi, K.; Berova, N.; Purrello, R. A Cationic Zinc Porphyrin as a Chiroptical Probe for Z-DNA. Angew. Chem. Int. Ed. 2005, 44, 4006 -4009.
178. Shaw, N.N.; Arya, D.P. Recognition of the unique structure of DNA: RNA hybrids. Biochimie, 2008, 90, 1026-1039.